Publication

Toward Meeting the Obligation of Respect for Persons in Pragmatic Clinical Trials

Downloadable Content

Persistent URL
Last modified
  • 09/24/2025
Type of Material
Authors
    Stephanie Morain, Johns Hopkins Berman Institute of BioethicsStephanie A Kraft, Seattle Children’s Research InstituteBenjamin S Wilfond, Seattle Children’s Research InstituteAmy Mcguire, Center for Medical Ethics & Health PolicyNeal Dickert, Emory UniversityAndrew Garland, Johns Hopkins Berman Institute of BioethicsJeremy Sugarman, Johns Hopkins Berman Institute of Bioethics
Language
  • English
Date
  • 2022-05-01
Publisher
  • Wiley
Publication Version
Copyright Statement
  • © 2022 The Hastings Center
Final Published Version (URL)
Title of Journal or Parent Work
Volume
  • 52
Issue
  • 3
Start Page
  • 9
End Page
  • 17
Abstract
  • Research ethics oversight systems have traditionally emphasized the informed consent process as the primary means by which to demonstrate respect for prospective subjects. Yet how researchers can best fulfill the ethical obligations of respect for persons in pragmatic clinical trials (PCTs)—particularly those that may alter or waive informed consent—remains unknown. We propose eight dimensions of demonstrating respect in PCTs: (1) engaging patients and communities in research design and execution, (2) promoting transparency and open communication, (3) maximizing agency, (4) minimizing burdens and promoting accessibility, (5) protecting privacy and confidentiality, (6) valuing interpersonal interactions with clinicians and study team members, (7) providing compensation, and (8) maximizing social value. While what respect requires in the context of PCTs will vary based on the nature of the PCT in question, the breadth of these dimensions demonstrates that respect obligations extend beyond informed consent processes.
Author Notes
  • Dr. Stephanie Morain, 1809 Ashland Ave, Baltimore, MD 21205. Email: smorain1@jhu.edu
Keywords

Tools

Relations

In Collection:

Items